10x Genomics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 20/04/2026 BST			5-day change	1st Jan Change
24.59 ^USD	-5.71%		+4.28%	+50.77%

04-19	10x Genomics Introduces Atera Platform	CI
03-31	10x Genomics Shares Rise After William Blair Upgrade	MT

Published on 02/12/2026 at 10:47 pm GMT - Modified on 02/14/2026 at 05:28 am GMT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Thank you for standing by. My name is Karli, and I will be your conference operator today. At this time, I would like to welcome everyone to the 10x

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

04-19	10x Genomics Introduces Atera Platform	CI
03-31	10x Genomics Shares Rise After William Blair Upgrade	MT
03-31	William Blair Upgrades 10x Genomics to Outperform From Market Perform	MT
02-20	UBS Adjusts Price Target on 10x Genomics to $20 From $14, Maintains Neutral Rating	MT
02-12	10x Genomics, Inc., Q4 2025 Earnings Call, Feb 12, 2026
02-12	(TXG) 10x Genomics Expects 2026 Revenue Range $600M-$625M, vs. FactSet Est of $611.6M	MT
02-12	10x Genomics Q4 Loss Narrows, Revenue Rises; 2026 Guidance Set	MT
02-12	Earnings Flash (TXG) 10x Genomics, Inc. Reports Q4 Revenue $166.0M, vs. FactSet Est of $159.7M	MT
02-12	10X Genomics, Inc. Provides Earnings Guidance for the Full Year 2026	CI
02-12	10x Genomics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-04	PharosAI and 10x Genomics partner to transform cancer research with AI and spatial biology	RE
02-04	Pharosai and 10X Genomics Partner to Transform Cancer Research with Ai and Spatial Biology	CI
02-04	10x Genomics, PharosAI Enter Cancer Research Partnership	MT
01-12	10x Genomics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 08:15 AM
01-12	Cancer Research Institute Launches Transformative Ai-Driven Immuno-Oncology Initiative Powered by 10X Genomics Technology	CI